KPTI
Karyopharm Therapeutics Inc
Price:  
0.99 
USD
Volume:  
1,445,091.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KPTI EV/EBITDA

-2292.6%
Upside

As of 2024-05-29, the EV/EBITDA ratio of Karyopharm Therapeutics Inc (KPTI) is -2.95. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KPTI's latest enterprise value is 389.92 mil USD. KPTI's TTM EBITDA according to its financial statements is -132.06 mil USD. Dividing these 2 quantities gives us the above KPTI EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.7x - 19.7x 15.0x
Forward P/E multiples 16.5x - 22.0x 19.7x
Fair Price (20.85) - (24.47) (21.78)
Upside -2198.9% - -2562.5% -2292.6%
0.99 USD
Stock Price
(21.78) USD
Fair Price

KPTI EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-28 -2.95
2024-05-24 -3.00
2024-05-23 -3.04
2024-05-22 -3.06
2024-05-21 -3.07
2024-05-20 -3.08
2024-05-17 -3.09
2024-05-16 -3.08
2024-05-15 -3.07
2024-05-14 -3.04
2024-05-13 -3.07
2024-05-10 -3.04
2024-05-09 -3.02
2024-05-08 -2.98
2024-05-07 -3.05
2024-05-06 -3.09
2024-05-03 -3.07
2024-05-02 -3.03
2024-05-01 -3.03
2024-04-30 -2.99
2024-04-29 -3.05
2024-04-26 -3.01
2024-04-25 -3.01
2024-04-24 -3.04
2024-04-23 -3.04
2024-04-22 -3.07
2024-04-19 -3.11
2024-04-18 -3.21
2024-04-17 -3.30
2024-04-16 -3.05
2024-04-15 -3.10
2024-04-12 -3.15
2024-04-11 -3.26
2024-04-10 -3.20
2024-04-09 -3.26
2024-04-08 -3.27
2024-04-05 -3.28
2024-04-04 -3.25
2024-04-03 -3.21
2024-04-02 -3.31
2024-04-01 -3.48
2024-03-28 -3.41
2024-03-27 -3.39
2024-03-26 -3.31
2024-03-25 -3.31
2024-03-22 -3.31
2024-03-21 -3.33
2024-03-20 -3.32
2024-03-19 -3.29
2024-03-18 -3.38